Article
Psychedelic Frontiers of Western Medicine
Johns Hopkins and Yale Schools of Medicine reviewed dozens of studies and recent trials on psychedelic compounds.
Article
Johns Hopkins and Yale Schools of Medicine reviewed dozens of studies and recent trials on psychedelic compounds.
Article
“On Tuesday, you will be the only person in the U.S. who will be taking psilocybin legally.”
Article
“Too many people just see ayahuasca as a sales product and that’s a problem, where it becomes commodified.”
Article
The 10th Horizons: Perspectives on Psychedelics conference is this weekend (Oct 7-9) in NYC. So we asked some people to chime in and offer their Psychedelic Perspectives on Horizons.
Article
Canada has amended its policies on heroin to allow doctors to prescribe the drug to patients suffering severe addiction.
Article
In this interview I talk with Dorion Sagan about whether his father Carl Sagan used LSD, his mother Lynn Margulis’s paradigm-changing theory of symbiogenesis, her thoughts on psychedelics, and his new book Cracking the Aging Code: The New Science of Growing Old-And What It Means for Staying Young.
Article
We talked with Amanda Feilding about LSD, psychedelic neuroscience, Beckley Foundation’s latest research, and her promise to Albert Hofmann.
Article
Inspired by a scientific study showing that psilocybin mushrooms can potentially cure OCD, Adam Strauss embarked on vigilante psychopharmacology.
Article
‘Co-production’ refers to processes in which a range of experts and non-experts are enrolled as researchers and attempt to generate knowledge together.
Psymposia is a research and media 501(c)(3) nonprofit that offers critical perspectives on drugs, politics, and culture.
We rely on audience support to keep our work independent and focused on the public interest. You can sustain Psymposia by becoming a member, which includes exclusive content and perks.